Advanced search
Add to list

Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study

Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
VAN LAETHEM, J., et al. “Gemcitabine and Oxaliplatine (GEMOX) in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Phase II Study.” Journal of Clinical Oncology, vol. 22, no. 14S, 2004, p. 343.
APA
VAN LAETHEM, J., POLUS, M., MARECHAL, R., DEMOLS, A., GAY, F., MARIJKEN, M., … Peeters, M. (2004). Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study. Journal of Clinical Oncology, 22(14S), 343.
Chicago author-date
VAN LAETHEM, J, M POLUS, R MARECHAL, A DEMOLS, F GAY, M MARIJKEN, A HENDLISZ, and Marc Peeters. 2004. “Gemcitabine and Oxaliplatine (GEMOX) in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Phase II Study.” In Journal of Clinical Oncology, 22:343.
Chicago author-date (all authors)
VAN LAETHEM, J, M POLUS, R MARECHAL, A DEMOLS, F GAY, M MARIJKEN, A HENDLISZ, and Marc Peeters. 2004. “Gemcitabine and Oxaliplatine (GEMOX) in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Phase II Study.” In Journal of Clinical Oncology, 22:343.
Vancouver
1.
VAN LAETHEM J, POLUS M, MARECHAL R, DEMOLS A, GAY F, MARIJKEN M, et al. Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study. In: Journal of clinical oncology. 2004. p. 343.
IEEE
[1]
J. VAN LAETHEM et al., “Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study,” in Journal of clinical oncology, 2004, vol. 22, no. 14S, p. 343.
@inproceedings{319176,
  author       = {{VAN LAETHEM, J and POLUS, M and MARECHAL, R and DEMOLS, A and GAY, F and MARIJKEN, M and HENDLISZ, A and Peeters, Marc}},
  booktitle    = {{Journal of clinical oncology}},
  issn         = {{0732-183X}},
  language     = {{und}},
  number       = {{14S}},
  pages        = {{343s-343s}},
  title        = {{Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study}},
  volume       = {{22}},
  year         = {{2004}},
}